SINUVA Sinus Implant

The SINUVA Sinus Implant is a steroid-releasing (mometasone furoate) implant indicated for the treatment of nasal polyps. SINUVA may be an alternative to sinus surgery and other treatment options.

SINUVA is an innovative technology that reduces polyps and the sensation of nasal congestion and obstruction with a 2-in-1 approach:

  1. Designed to open in the sinus cavity
  2. Delivers anti-inflammatory medicine to treat nasal polyps

Benefits of SINUVA Sinus Implant

The SINUVA Sinus Implant was introduced as an additional therapy option for patients who had recurring nasal polyps after sinus surgery. SINUVA helps patients to

  • Reduce nasal congestion and nasal polyps
  • Improve an impaired sense of smell
  • Reduce the need for further sinus surgery

SINUVA Is An In-Office Procedure

SINUVA is placed in your doctor’s office using topical and/or local anesthesia to numb your nose and sinuses. After numbing your nose, your doctor will introduce the SINUVA implant into your nostril at the end of a delivery system, and place the implant within your sinus. SINUVA usually cannot be felt once it is in place.

Typically, the procedure takes 30-40 minutes. This includes 10-30 minutes to numb your nose and around 5-10 minutes to place the SINUVA implant.

How SINUVA Works to Reduce Nasal Polyps

SINUVA is implanted in your sinus cavity next to the nasal polyps to provide local delivery of a drug called mometasone furoate (a type of steroid). The implant has been shown to be effective in reducing nasal obstruction and congestion and shrinking polyps.

SINUVA Sinus Implant: How It Works Video

SINUVA Sinus Implant Available at CT Sinus Center

If you are interested in the SINUVA Sinus Implant as an in-office treatment for recurrent nasal polyps, call CT Sinus Center at (203) 574-5997 to schedule a consultation. You may also request an appointment online.

SINUVA Sinus Implant FAQs

Your doctor will always be evaluating your condition for the right treatment option. Explore if SINUVA is right for you. Express your desire for an alternative to surgery and current treatment options. Here are a few questions you can use to get the conversation started:

  • I’ve read about SINUVA. Do you think it’s right for me?
  • I don’t want any more surgery. What are my other options?
  • Can SINUVA help shrink my nasal polyps?
  • What are the risks of SINUVA?

By asking questions and starting a conversation, you’ll be helping your doctor plan the right treatment for you.

The most common adverse reactions observed in clinical studies were bronchitis, nasopharyngitis, upper respiratory or middle ear infection, headache, lightheadedness, asthma, and nose bleed.

Patients experiencing excessive nasal bleeding, symptoms of infection or symptoms suggesting that the implant has moved, such as irritation or a choking sensation in the back of the throat, should immediately contact a healthcare professional.

Close monitoring is recommended if patients have a change of vision or a history of increased intraocular pressure, glaucoma, and/or cataracts.

As with all endoscopic sinus procedures, there are risks associated with the insertion and removal of SINUVA Sinus Implant. For that reason, SINUVA should only be inserted by physicians trained in Otolaryngology.

The placement-related risks include nose bleed, injuries to blood vessels, and bacterial infection.

Based on the results of the two clinical trials, the most common side effects were asthma, headache, and nose bleed.

Because SINUVA is placed directly amongst the nasal polyps, it is able to provide sustained symptom relief with a low rate of side effects. The safety of SINUVA was established in 400 patients in two clinical trials.

SINUVA Sinus Implant is intended for use in patients 18 years of age or older who have had ethmoid sinus surgery.

After approval by your insurance, SINUVA is sent directly to your doctor’s office. Your doctor will then place the implant to treat your nasal polyps.

Many insurance policies will cover SINUVA. Check with your insurance provider to see if this treatment option is covered under your policy.

SINUVA is approved by the FDA. It is available by prescription only.

SINUVA is not indicated for patients who

  • Have a known hypersensitivity to the mometasone furoate drug or any of the ingredients in SINUVA.
  • Have nasal ulcers or nasal trauma.

SINUVA treatment is ideal for adults who have had ethmoid sinus surgery before but now have nasal polyps.

SINUVA is proven to shrink nasal polyps and reduce nasal obstruction and congestion. As it stays in the sinus and continues to release medicine, SINUVA offers sustained symptom relief for up to 90 days.

As the implant softens and polyps decrease, the implant may, in part or in whole, be expelled out of the nose on its own or with actions such as sneezing or forceful nose-blowing.

SINUVA is designed to deliver the drug over the course of 90 days and may be removed at that time or earlier at your doctor’s discretion.

The implant is designed to release medicine over the course of 90 days. The implant gradually softens over time while it is in your sinus.

You should consult with your physician to determine the right therapy plan for you.

Yes, you are encouraged to use both saline irrigations and nasal sprays as directed by your physician.

The approximate length of SINUVA is 20 mm. When prepared for the procedure, the implant will be compressed to a size that is comparable to the head of a cotton swab.

Each SINUVA Implant contains 1350 mcg of mometasone furoate.